Publications

Nyffeler J, Willis C, Harris FR, Foster MJ, Chambers B, Culbreth M, Brockway RE,…, Patlewicz G, et al. 2023. Application of cell painting for chemical hazard evaluation in support of screening-level chemical assessments. Toxicol Appl Pharmacol 468(June 1):116513; doi: 10.1016/j.taap.2023.116513. PMID: 37044265.

Rogers JM, Heintz MM, Thompson CM, Haws LC. 2023. A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per- and polyfluoroalkyl substances and relevance to human health. Birth Defects Res 115(11)1011-1062; doi: 10.1002/bdr2.2185. PMID: 37219003.

Patlewicz G, Paul Friedman K, Houck K, Zhang L, Huang R, Xia M, Brown J, Simmons SO. 2023. Evaluating the utility of a high throughput thiol-containing fluorescent probe to screen for reactivity: A case study with the Tox21 library. Comput Toxicol 26(May):100271; doi: 10.1016/j.comtox.2023.100271. PMID: 37388277.

Meek ME, Wikoff D. 2023. The need for good practice in the application of mechanistic constructs in hazard and risk assessment. Toxicol Sci 194(1):13-22; doi: 10.1093/toxsci/kfad039. PMID: 3707944.

Britt JK. 2023. Insect repellents (DEET) and others. In: Patty’s Industrial Hygiene and Toxicology. John Wiley & Sons; https://doi.org/10.1002/0471125474.tox140.

Wood CT, Walter E, Espinosa CM, Enriquez-Bruce ME, Budhecha S, Elliott A, Domachowske J,…, Suh M, et al. Seasonality of infant lower respiratory tract infections, including those caused by RSV, was altered during the COVID-19 pandemic: Results from four US health systems. Poster #642 at the Pediatric Academic Societies Meeting, Washington, DC, April 2023.

Suh M, Reichert H, Jiang X, Pastula ST, Movva N, Fryzek J, Simoes E. The burden of RSV and bronchiolitis in the US infant Medicaid population extends beyond the inpatient setting. Oral presentation to the Pediatric Academic Societies Meeting, Washington, DC, April 2023.

Klaren WD, Heintz MM, East AW, Thompson CM, Haws LC. In vitro transcriptomic analyses informing the mode of action of HFPO-DA (GenX) in the liver. Poster presented at Society of Toxicology 62nd Annual Meeting, Nashville, TN, March 2023.

Thompson CM, Heintz MM, Wolf JC, Cheru R, Haws LC, Cullen JM. 2023. Assessment of mouse liver histopathology following exposure to HFPO-DA with emphasis on understanding mechanisms of hepatocellular death. Toxicol Pathol 51(1–2):4–14; doi: 10.1177/01926233231159078. PMID: 36987989.

Heintz MM, Haws LC, Klaunig JE, Cullen JM, Thompson CM. 2023. Assessment of the mode of action underlying development of liver lesions in mice following oral exposure to HFPO-DA and relevance to humans. Toxicol Sci 192(1):15–29; doi: 10.1093/toxic/kfad004. PMID: 36629480.